Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

4,555JPY
17 Nov 2017
Change (% chg)

¥155 (+3.52%)
Prev Close
¥4,400
Open
¥4,575
Day's High
¥4,630
Day's Low
¥4,495
Volume
208,700
Avg. Vol
147,723
52-wk High
¥4,725
52-wk Low
¥2,133

Latest Key Developments (Source: Significant Developments)

JCR Pharmaceuticals to initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo.  Full Article

NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:* Says it and NanoCarrier Co., Ltd <4571.T> conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines .* Under this agreement, Nanocarrier and JCR will integrate the unique technologies and knowledge of both companies, and aim to develop an innovative drug effectively delivered to the brain .  Full Article

PeptiDream signs collaborative research agreement with JCR Pharmaceuticals
Monday, 22 Feb 2016 

PeptiDream Inc:Says signed collaborative research agreement with JCR Pharmaceuticals for development of special cyclic peptide for target protein.  Full Article

JCR Pharmaceuticals and MEDIPAL HOLDINGS launch new product TEMCELL
Tuesday, 16 Feb 2016 

JCR Pharmaceuticals Co Ltd:The company and MEDIPAL HOLDINGS CORPORATION announced that TEMCELL® HS Inj. (human (allogeneic) bone marrow derived mesenchymal stem cells) which was approved for marketing in September last year, will become available on Feb. 24.Says will be distributed utilizing the ultra-low cold chain system developed jointly with MEDIPAL.  Full Article